MRPS18B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.475000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.570600E-01
Normal-vs-Stage2
2.434000E-01
Normal-vs-Stage3
2.094400E-02
Normal-vs-Stage4
1.185800E-01
Stage1-vs-Stage2
7.359400E-01
Stage1-vs-Stage3
8.927600E-02
Stage1-vs-Stage4
7.701200E-01
Stage2-vs-Stage3
2.208300E-02
Stage2-vs-Stage4
9.256800E-01
Stage3-vs-Stage4
8.564500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.554600E-01
Normal-vs-AfricanAmerican
4.193500E-02
Normal-vs-Asian
3.293000E-01
Caucasian-vs-AfricanAmerican
9.740600E-01
Caucasian-vs-Asian
9.368600E-01
AfricanAmerican-vs-Asian
9.588600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.501400E-01
Normal-vs-Female
2.581800E-01
Male-vs-Female
9.101800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.255100E-03
Normal-vs-Age(41-60Yrs)
1.958640E-01
Normal-vs-Age(61-80Yrs)
2.191000E-01
Normal-vs-Age(81-100Yrs)
9.951600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.260600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.415200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.839700E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.382200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.222000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.156300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.927800E-01
Normal-vs-Daily Drinker
4.270500E-02
Normal-vs-Weekly Drinker
9.690000E-02
Normal-vs-Occasional Drinker
5.998400E-01
Normal-vs-Social Drinker
2.574100E-02
Non Drinker-vs-Daily Drinker
2.475600E-01
Non Drinker-vs-Weekly Drinker
4.329200E-01
Non Drinker-vs-Occasional Drinker
5.392300E-02
Non Drinker-vs-Social Drinker
9.729200E-01
Daily Drinker-vs-Weekly Drinker
8.463200E-01
Daily Drinker-vs-Occasional Drinker
9.953900E-04
Daily Drinker-vs-Social Drinker
1.395410E-01
Weekly Drinker-vs-Occasional Drinker
8.100500E-03
Weekly Drinker-vs-Social Drinker
3.492600E-01
Occasional Drinker-vs-Social Drinker
1.409650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.555400E-01
Normal-vs-Grade 2
2.195400E-01
Normal-vs-Grade 3
1.724600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.902400E-01
Grade 1-vs-Grade 3
6.172600E-01
Grade 1-vs-Grade 4
2.555400E-01
Grade 2-vs-Grade 3
9.589800E-01
Grade 2-vs-Grade 4
2.195400E-01
Grade 3-vs-Grade 4
1.724600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.445600E-01
Normal-vs-NonDiabetic
1.959160E-01
Diabetic-vs-NonDiabetic
8.783400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.602700E-03
Normal-vs-NoPancreatitis
2.550600E-01
Pancreatitis-vs-NoPancreatitis
2.152300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.739410E-01
Normal-vs-N1
2.719000E-01
N0-vs-N1
8.438800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.367200E-01
Normal-vs-TP53-NonMutant
5.681600E-01
TP53-Mutant-vs-TP53-NonMutant
2.138000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
